Minirin Melt (Desmopressin)

Desmopressin, the active ingredient in Minirin Melt, is a vasopressin analog presented as a melt tablet for sublingual use. It selectively stimulates renal V2 receptors, enhancing water reabsorption without significant vasoconstrictive activity. It helps manage central diabetes insipidus, nocturnal enuresis, and primary nocturnal polyuria in patients requiring antidiuretic therapy.

GNH USA supplies Minirin Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements across multiple markets. The company ensures consistent batch release and provides comprehensive documentation to support import and clinical use.

Desmopressin is a synthetic vasopressin analog that acts on the renal water‑reabsorption pathway.

- Central diabetes insipidus: reduces excessive urine output by enhancing water reabsorption in the kidneys. - Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine. - Primary nocturnal polyuria: lowers nocturnal urine volume, improving sleep continuity.

Desmopressin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate headache reported. - Nasal congestion: sensation of blocked nose. - Nausea: occasional feeling of nausea. - Hyponatremia (mild): slight reduction in serum sodium levels.

Serious or Rare Side Effects: - Severe hyponatremia: marked low sodium that can cause seizures. - Water intoxication: excessive water retention leading to edema. - Allergic reactions: rash, itching, or anaphylaxis.

When prescribing desmopressin, clinicians should consider several precautionary measures to ensure safe use.

- Assess fluid balance: evaluate patient’s hydration status before initiating therapy. - Monitor electrolytes: regularly check serum sodium, especially in the elderly or those on diuretics. - Limit fluid intake: advise patients to restrict excessive water consumption while on treatment. - Caution in renal impairment: adjust use or avoid in severe kidney dysfunction. - Avoid in uncontrolled hypertension: due to potential fluid retention. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Desmopressin can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Concomitant use with carbamazepine: may reduce desmopressin effectiveness. - Co‑administration with diuretics (especially thiazides): increases risk of hyponatremia. - Concurrent use with selective serotonin reuptake inhibitors (SSRIs): may potentiate hyponatremia.

Moderate Interactions (Monitor Closely): - NSAIDs: may enhance antidiuretic effect and fluid retention. - Anticoagulants: potential for altered bleeding risk due to fluid shifts. - Alcohol: can exacerbate hyponatremia risk.